drugset / Trial / NCT05048784

A Study to Compare the Pharmacokinetics of Two Different Tablets of Sotorasib in Healthy Participants

NCT05048784

Phase 1 Completed 145 enrolled Amgen
RandomizedCrossoverOpen-labelBasic science

Summary

The primary objective of this study is to compare the pharmacokinetics (PK) of sotorasib dose A administered orally as 3 tablets (test) to sotorasib dose A administered orally as 8 tablets (reference).

Timeline

Start
2021-08-16
Primary completion
2022-02-18
Completion
2022-02-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Sotorasib Small molecule Oral

Indications

No indication recorded.